ambroxol has been researched along with Liver Diseases in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Liver Diseases: Pathological processes of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury." | 8.12 | Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022) |
"The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury." | 4.12 | Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats? ( Cetinel, S; Gultekin, C; Sayiner, S; Sehirli, AO, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gultekin, C | 1 |
Sehirli, AO | 1 |
Cetinel, S | 1 |
Sayiner, S | 1 |
1 other study available for ambroxol and Liver Diseases
Article | Year |
---|---|
Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats?
Topics: Ambroxol; Animals; Cytokines; Ischemia; Liver; Liver Diseases; Rats; Rats, Wistar; Reperfusion Injur | 2022 |